The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase

  • Anna A. Sablina
  • , Wen Chen
  • , Jason D. Arroyo
  • , Laura Corral
  • , Melissa Hector
  • , Sara E. Bulmer
  • , James A. DeCaprio
  • , William C. Hahn

Research output: Contribution to journalArticlepeer-review

Abstract

The serine-threonine protein phosphatase 2A (PP2A) is a heterotrimeric enzyme family that regulates numerous signaling pathways. Biallelic mutations of the structural PP2A Aβ subunit occur in several types of human tumors; however, the functional consequences of these cancer-associated PP2A Aβ mutations in cell transformation remain undefined. Here we show that suppression of PP2A Aβ expression permits immortalized human cells to achieve a tumorigenic state. Cancer-associated Aβ mutants fail to reverse tumorigenic phenotype induced by PP2A Aβ suppression, indicating that these mutants function as null alleles. Wild-type PP2A Aβ but not cancer-derived Aβ mutants form a complex with the small GTPase RalA. PP2A Aβ-containing complexes dephosphorylate RalA at Ser183 and Ser194, inactivating RalA and abolishing its transforming function. These observations identify PP2A Aβ as a tumor suppressor gene that transforms immortalized human cells by regulating the function of RalA.

Original languageEnglish
Pages (from-to)969-982
Number of pages14
JournalCell
Volume129
Issue number5
DOIs
StatePublished - Jun 1 2007

Keywords

  • HUMDISEASE
  • PROTEINS

Fingerprint

Dive into the research topics of 'The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase'. Together they form a unique fingerprint.

Cite this